Silver Book Fact

Several prevention/early detection interventions for cardiovascular disease have cost-effectiveness ratios of $50,000-$70,000 per life saved.

Pearson T. The Prevention Of Cardiovascular Disease: Have we really made progress?. Health Affairs. 2007; 26(1): 49-60. https://pubmed.ncbi.nlm.nih.gov/17211013/

Reference

Title
The Prevention Of Cardiovascular Disease: Have we really made progress?
Publication
Health Affairs
Publisher
Project HOPE
Publication Date
2007
Authors
Pearson T
Volume & Issue
Volume 26, Issue 1
Pages
49-60
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • A calculated approximate benefit-to-cost ratio for antihypertensive therapy is 10:1 for men and 6:1 for women.  
  • Death rates from heart disease have decreased from 586.6 deaths per 100,000 persons in 1950, to 240.8 deaths per 100,000 persons in 2002.  
  • Between 1988 & 1994 and 1999 & 2004, use of pharmacological lipid-lowering treatment increased from 11.7% to 40.8%. Low-density lipoprotein cholesterol control increased from 4.0% to 25.1% among those with high…  
  • While treatment with antihypertensives has already generated a benefit-to-cost ratio of at least 6:1 (6:1 for women and 10:1 for men), more effective use of antihypertensive medication would have an…  
  • Following the current path, heart disease cases will increase by 41.1% between 2003 and 2023. If an alternative path is taken, there will be 34.6% (9.4 million) fewer heart disease…